Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter TNFRSF13C (Ianalumab Biosimilar) Antikörper

This anti-TNFRSF13C (Ianalumab Biosimilar) antibody (ABIN7581716) is a Human Monoclonal antibody detecting TNFRSF13C (Ianalumab Biosimilar) in ELISA, FACS, BLI, Func, SPR. Suitable for Human.
Produktnummer ABIN7581716

Quick Overview for Rekombinanter TNFRSF13C (Ianalumab Biosimilar) Antikörper (ABIN7581716)

Target

TNFRSF13C (Ianalumab Biosimilar)

Antikörpertyp

Recombinant Antibody

Reaktivität

Human

Wirt

  • 4
  • 1
Human

Klonalität

  • 5
Monoklonal

Konjugat

  • 3
  • 1
  • 1
Dieser TNFRSF13C (Ianalumab Biosimilar) Antikörper ist unkonjugiert

Applikation

ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expressionssystem

    CHO Cells

    Verwendungszweck

    Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab)

    Sequenz

    DIVLTQSPAT LSLSPGERAT LSCRASQFIS SSYLSWYQQK PGQAPRLLIY GSSSRATGVP ARFSGSGSGT DFTLTISSLE PEDFAVYYCQ QLYSSPMTFG QGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC,QVQLQQSGPG LVKPSQTLSL TCAISGDSVS SNSAAWGWIR QSPGRGLEWL GRIYYRSKWY NSYAVSVKSR ITINPDTSKN QFSLQLNSVT PEDTAVYYCA RYDWVPKIGV FDSWGQGTLV TVSSASTKGP SVFPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSCDKT HTCPPCPAPE LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPGK

    Produktmerkmale

    Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Reinheit

    >95 %

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    Therapeutic Agents by Target and Mechanism: BAFFR inhibitors

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Konzentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Lagerung

    4 °C,-80 °C

    Informationen zur Lagerung

    +4°C,-80°C
  • Target

    TNFRSF13C (Ianalumab Biosimilar)

    Substanzklasse

    Biosimilar

    Molekulargewicht

    145.5 kDa

    UniProt

    Q96RJ3
Sie sind hier:
Chat with us!